white and blue magnetic card

Photo by Avery Evans on unsplash

Capital One Eyes Discover Financial Merger

February 19, 2024

In a potentially massive move for the credit card industry, reports suggest that Capital One is contemplating acquiring Discover Financial. If this deal goes through, it would merge two of the country’s biggest credit card giants, creating a behemoth in the sector.

According to sources familiar with the matter, the Wall Street Journal hinted that an announcement regarding the acquisition could happen as soon as Tuesday. Bloomberg had previously reported Capital One’s interest in acquiring the Illinois-based Discover Financial.

The proposed acquisition would be Capital One’s largest deal to date, marking a significant milestone for the Virginia-based bank. While the specifics of the financial arrangement remain unclear, it’s believed that Capital One intends to seal the deal through an all-stock transaction.


Currently, Capital One primarily issues credit cards affiliated with Visa and Mastercard, whereas Discover Financial not only issues cards but also operates its own payment network, competing directly with the likes of Visa in facilitating credit card transactions.

In terms of financial magnitude, Capital One towers with an approximate valuation of $52.2 billion in the public market, while Discover Financial stands at about $27.6 billion.

Interestingly, if this merger materializes, it could potentially rank among the largest global acquisitions of 2024. Bloomberg noted that the top deal thus far this year was Synopsys’ acquisition of Ansys, a software manufacturer, valued at around $34 million.


As of now, neither Capital One nor Discover Financial has provided any official comments regarding the reported acquisition, as they didn’t immediately respond to requests for comment from Forbes.

In the realm of finance, mergers and acquisitions often reshape the landscape of industries, and if Capital One successfully absorbs Discover Financial, it could alter the dynamics of the credit card sector significantly. This potential merger underscores the ever-evolving nature of the financial services industry, where competition and consolidation go hand in hand.

Recent News

Massive Data Breach Hits Ticketmaster, Affecting 560 Million Customers

Ticketmaster has fallen victim to a significant cyber-attack, potentially compromising the data of up to 560 million customers. The breach was confirmed by Ticketmaster’s parent company, Live Nation, which revealed that a notorious hacking group, ShinyHunters, is behind the attack. The hackers are demanding a ransom of approximately £400,000 to prevent the data from being sold on the dark web.

Toyota Recalls 100,000+ Tundra and Lexus LX SUVs Over Engine Debris Issue

Toyota has announced a recall for over 100,000 Tundra pickups and Lexus LX SUVs in North America due to potential engine issues caused by machining debris. This recall affects certain 2022-2023 models of the Tundra and LX, which are equipped with the new V6 twin-turbo engine. The V6 twin-turbo engine has faced considerable scrutiny regarding its reliability, especially when compared to the previous naturally aspirated V8 engines.

Wordle and Worldle Battle Over Names

A legal dispute has erupted between the wildly popular word game Wordle and the lesser-known geography game Worldle, centering on the similarity of their names. Wordle, which was developed by Josh Wardle in 2021 and later acquired by the New York Times in 2022 for a substantial sum, has gained immense popularity. In this game, players have six attempts to guess a five-letter word. 

FDA Issues Recall for Crecelac Goat Milk Infant Formula

The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding Crecelac Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. The alert highlights Cronobacter contamination concerns with Crecelac Infant Powdered Goat Milk Infant Formula. Although Dairy Manufacturers Inc. initiated a recall on May 24, 2024, due to non-compliance with FDA regulations, new findings of Cronobacter contamination have prompted further action.